These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29164586)

  • 1. Functions of microRNAs in osteoporosis.
    Ge DW; Wang WW; Chen HT; Yang L; Cao XJ
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4784-4789. PubMed ID: 29164586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis.
    Sun M; Zhou X; Chen L; Huang S; Leung V; Wu N; Pan H; Zhen W; Lu W; Peng S
    Biomed Res Int; 2016; 2016():1652417. PubMed ID: 27073801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of microRNAs in bone remodeling and its therapeutic implications for osteoporosis.
    Feng Q; Zheng S; Zheng J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29848766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of circular RNAs in osteogenic/osteoclastogenic differentiation.
    Wang T; Zhang C; Xu L; Li X
    Biofactors; 2024; 50(1):6-15. PubMed ID: 37534732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of downregulated microRNAs during osteoclast formation and osteoporosis progression.
    Ma Y; Shan Z; Ma J; Wang Q; Chu J; Xu P; Qin A; Fan S
    Mol Med Rep; 2016 Mar; 13(3):2273-80. PubMed ID: 26783047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA functions in osteogenesis and dysfunctions in osteoporosis.
    van Wijnen AJ; van de Peppel J; van Leeuwen JP; Lian JB; Stein GS; Westendorf JJ; Oursler MJ; Im HJ; Taipaleenmäki H; Hesse E; Riester S; Kakar S
    Curr Osteoporos Rep; 2013 Jun; 11(2):72-82. PubMed ID: 23605904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of miRNAs, lncRNAs and circRNAs on osteoporosis as regulatory factors of bone homeostasis (Review).
    Li Z; Xue H; Tan G; Xu Z
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microRNAs in progenitor cell commitment and osteogenic differentiation in health and disease (Review).
    Valenti MT; Dalle Carbonare L; Mottes M
    Int J Mol Med; 2018 May; 41(5):2441-2449. PubMed ID: 29393379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated miRNAs in bone health: Epigenetic roles in osteoporosis.
    Bellavia D; De Luca A; Carina V; Costa V; Raimondi L; Salamanna F; Alessandro R; Fini M; Giavaresi G
    Bone; 2019 May; 122():52-75. PubMed ID: 30772601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis and inflammation: Cause to effect or comorbidity?
    Khoury MI
    Int J Rheum Dis; 2024 Oct; 27(10):e15357. PubMed ID: 39352013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microRNAs in osteoclasts and osteoporosis.
    Tang P; Xiong Q; Ge W; Zhang L
    RNA Biol; 2014; 11(11):1355-63. PubMed ID: 25692234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis: a neuroskeletal disease?
    Takeda S
    Int J Biochem Cell Biol; 2009 Mar; 41(3):455-9. PubMed ID: 18761104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis: A Frontier in Osteoporosis.
    Maheshwari S; Singh A; Verma A
    Horm Metab Res; 2024 Sep; 56(9):625-632. PubMed ID: 38307092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3: A Potential Target of Different Types of Osteoporosis.
    Pan B; Chen C; Zhao Y; Cai J; Fu S; Liu J
    Cell Biochem Biophys; 2024 Jun; 82(2):489-500. PubMed ID: 38512537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.
    Zhang Y; Su J; Wu S; Teng Y; Yin Z; Guo Y; Li J; Li K; Yao L; Li X
    Sci Signal; 2015 Mar; 8(369):ra31. PubMed ID: 25805889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones.
    De-Ugarte L; Yoskovitz G; Balcells S; Güerri-Fernández R; Martinez-Diaz S; Mellibovsky L; Urreizti R; Nogués X; Grinberg D; García-Giralt N; Díez-Pérez A
    BMC Med Genomics; 2015 Nov; 8():75. PubMed ID: 26555194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sFRP4-dependent Wnt signal modulation is critical for bone remodeling during postnatal development and age-related bone loss.
    Haraguchi R; Kitazawa R; Mori K; Tachibana R; Kiyonari H; Imai Y; Abe T; Kitazawa S
    Sci Rep; 2016 Apr; 6():25198. PubMed ID: 27117872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix networks in bone remodeling.
    Alford AI; Kozloff KM; Hankenson KD
    Int J Biochem Cell Biol; 2015 Aug; 65():20-31. PubMed ID: 25997875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Bone Metabolism by microRNAs.
    Taipaleenmäki H
    Curr Osteoporos Rep; 2018 Feb; 16(1):1-12. PubMed ID: 29335833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miRNAs in bone and their potential as therapeutic targets.
    Kim KM; Lim SK
    Curr Opin Pharmacol; 2014 Jun; 16():133-41. PubMed ID: 24907412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.